Drug
Finerenone Oral Tablet
Finerenone Oral Tablet is a pharmaceutical drug with 4 clinical trials. Currently 3 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(75%)
Phase Distribution
Ph phase_2
1
25%
Ph phase_4
3
75%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting3
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 43 (75.0%)
Trials by Status
enrolling_by_invitation125%
recruiting375%
Recent Activity
3 active trials
Showing 4 of 4
recruitingphase_2
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
NCT06059664
recruitingphase_4
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
NCT07397650
enrolling_by_invitationphase_4
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
NCT06954090
recruitingphase_4
Finerenone for Patients With Primary Aldosteronism (FAIRY)
NCT06457074
Clinical Trials (4)
Showing 4 of 4 trials
NCT06059664Phase 2
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
NCT07397650Phase 4
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
NCT06954090Phase 4
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
NCT06457074Phase 4
Finerenone for Patients With Primary Aldosteronism (FAIRY)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4